| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GRAM domain containing 1B | 0.736 | 0.385 | 1.00 |
|
disease | 0.100 | None | 1.000 | 7 | 4 | 2008 | 2017 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.320 | None | 1.000 | 7 | 0 | 1997 | 2011 | ||||||||
|
MIR4435-2 host gene | 0.604 | 0.692 |
|
disease | 0.100 | None | 1.000 | 7 | 5 | 2008 | 2017 | |||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.370 | None | 1.000 | 7 | 0 | 1988 | 1998 | ||||||||
|
acyl-CoA oxidase like | 0.674 | 0.577 | 5.2E-15 |
|
disease | 0.100 | None | 1.000 | 7 | 5 | 2008 | 2017 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.150 | None | 1.000 | 7 | 3 | 1991 | 2016 | ||||||||
|
interferon regulatory factor 4 | 0.491 | 0.769 | 0.86 |
|
disease | 0.110 | None | 0.833 | 6 | 2 | 2000 | 2016 | ||||||||
|
downregulated RNA in cancer, inhibitor of cell invasion and migration | 0.736 | 0.423 |
|
disease | 0.100 | None | 1.000 | 6 | 3 | 2008 | 2017 | |||||||||
|
SP140 nuclear body protein | 0.691 | 0.577 | 5.0E-08 |
|
disease | 0.100 | None | 1.000 | 6 | 3 | 2008 | 2017 | ||||||||
|
immunoglobulin heavy variable 3-21 | 0.780 | 0.192 |
|
disease | 0.300 | None | 1.000 | 4 | 0 | 2011 | 2013 | |||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2016 | 2018 | ||||||||
|
solute carrier family 35 member B2 | 0.666 | 0.423 | 7.1E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1996 | 2005 | ||||||||
|
gametogenetin binding protein 1 (pseudogene) | 0.769 | 0.462 | 0.69 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2012 | 2017 | ||||||||
|
lymphoid enhancer binding factor 1 | 0.486 | 0.769 | 1.00 |
|
disease | 0.110 | None | 1.000 | 4 | 3 | 2013 | 2017 | ||||||||
|
BCL2 antagonist/killer 1 | 0.555 | 0.769 | 7.4E-06 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2012 | 2017 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2013 | 2017 | ||||||||
|
Bruton tyrosine kinase | 0.464 | 0.808 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
cancer susceptibility 19 | 0.769 | 0.423 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2013 | 2017 | |||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2013 | 2017 | |||||||||
|
B cell scaffold protein with ankyrin repeats 1 | 0.653 | 0.538 | 4.8E-12 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2017 | ||||||||
|
inhibitor of Bruton tyrosine kinase | 0.678 | 0.538 | 2.2E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.310 | None | 0.500 | 2 | 0 | 1999 | 2014 | ||||||||
|
protection of telomeres 1 | 0.560 | 0.731 | 0.85 |
|
disease | 0.400 | None | 1.000 | 2 | 1 | 2013 | 2014 | ||||||||
|
interferon regulatory factor 8 | 0.539 | 0.808 | 0.95 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2011 | 2014 | ||||||||
|
LIM domain containing preferred translocation partner in lipoma | 0.543 | 0.769 | 7.2E-03 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2017 |